[Etiotropic treatment of patients with early uterine carcinoma as a basis for prevention of relapses and complications].
In this paper, consideration is given to the role that etiological and pathogenetic factors have in the development of malignant tumours. Prevention of possible recurrencies and complications in patients with incipient forms of hysterocarcinoma warrant etiotropic treatment which has been shown to be effective and essential for the object to succeed in.